Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

Schivo acquires APN Global

admin by admin
November 15, 2022
in News


Schivo announced last week that it acquired APN Global and its APN Inc. operating subsidiary for an undisclosed amount.

Waterford, Ireland-based Schivo said in a news release that the acquisition further solidifies its presence in North America. It also allows APN to continue growing in Quebec.

The company will become the Schivo Group’s manufacturing center of excellence throughout the world.

“The acquisition of APN Global is strategically aligned with our vision to expand our presence in high-growth markets,” said Graham Reeves, Schivo CEO. “APN brings deep subject matter know-how and highly differentiated product and technology solutions to our portfolio. The coupling of this product, technology, and Industry 4.0 expertise with Schivo’s existing [minimally invasive surgical] and analytical systems knowledge will bring unparalleled capabilities to meet our customers’ needs. This synergistic coupling makes Schivo the partner of choice for developing the next generation of lifesaving and life-enhancing devices. We’re excited to welcome the Quebec team to Schivo. Their innovation, capabilities, and values perfectly complement Schivo’s.”

About APN Global

APN Global manufactures AFP valves, fittings and tubing technologies. Those apply to analytical instrumentation and minimally invasive surgical devices. The company incorporates autonomous robotics and fully closed-loop manufacturing. Schivo said APN is consistent with its strategy and increases its ability to offer its solutions in high-growth markets.

The Quebec site features a modern 60,000-square-foot facility. It offers extensive application engineering resources and manufacturing expertise. As part of the deal, Schivo brings Yves Proteau, co-president of APN Global, aboard as SVP of manufacturing and technology systems.

“The investment from Schivo comes at the perfect time for APN. Schivo, which operates in markets with great potential, is a company that has the ability to give APN the means to achieve its ambitions,” said Proteau. “Schivo, for its part, will benefit from the work carried out and the experience acquired by APN in recent years in industry 4.0 and process automation. My role will be to share this know-how with the other plants in the group. I am proud that Quebec know-how will be leveraged through the group worldwide. The APN team is happy to participate in this great adventure.”



Source link

Previous Post

More adverse reactions following bivalent COVID-19 mRNA booster vaccine

Next Post

One in four people with COPD waited more than five years for a diagnosis, research reveals

Next Post

One in four people with COPD waited more than five years for a diagnosis, research reveals

Recommended

Johnson Matthey opens medical nitinol facility in Mexico

6 months ago

Legal questions, inquiries intensify around Noble Health’s rural Missouri hospital closures

3 months ago

Why Medtronic’s paying up to $1B for Affera’s cardiac ablation tech

7 months ago

Age plays a more important role than genetics in affecting gene expression profiles as we get older

8 months ago

A Standard for Reporting Randomized Controlled Trials

2 months ago

Titan Medical shows off Enos surgical robot’s next-gen design

5 months ago
Medical-Writers-(-white-)

© Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.